Back to LCTX
Daiwa Securities Group Inc. → LCTX
Daiwa Securities Group Inc. LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
6
Latest value
$753K
Q3 2026
Peak value
$937K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $307K |
| Q3 2025 | $810K |
| Q4 2025 | $766K |
| Q1 2026 | $740K |
| Q2 2026 | $937K |
| Q3 2026 | $753K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $753K | 22.1K | — | — |
| Q2 2026 | $937K | 21.7K | — | — |
| Q1 2026 | $740K | 22.6K | — | — |
| Q4 2025 | $766K | 21.9K | — | — |
| Q3 2025 | $810K | 21.0K | — | — |
| Q3 2025 | $307K | 7.9K | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M